// App-Quantinova.ai

10038 : A retrospective study from the Royal Marsden Hospital (RMH) of patients with malignant perivascular epithelioid cell tumors (PEComa) receiving treatment with sirolimus (SI) or temsirolimus (TSI).

Researchers

Presenter

  • Joanna Vitfell Pedersen

Principal Investigators

  • Charlotte Benson

  • Nina Tunariu

  • Scott Mitchell

  • Cyril Fisher

  • Khin Thway

  • James M. G. Larkin

  • Michelle Scurr

  • Ian Robert Judson

Medical Centers

  • The Royal Marsden Hospital, London, United Kingdom

  • Sarcoma Unit, The Royal Marsden hospital, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Sarcoma Unit, The Royal Marsden hospital, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Perivascular epithelioid cell tumors

  • Sarcoma

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Temsirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved